Corrigendum to “Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy” [Epilepsy Res. (2023) 191 107112]
Titel:
Corrigendum to “Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy” [Epilepsy Res. (2023) 191 107112]
Auteur:
Sullivan, Joseph Gunning, Boudewijn Zafar, Muhammad Guerrini, Renzo Gecz, Jozef Kolc, Kristy L. Zhao, Yufan Gasior, Maciej Aimetti, Alex A. Samanta, Debopam